Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?

Kenichi Kaneko, Ryosuke Miyasaka, Roslyn Hayman

Open source

DOI: 10.1371/journal.pone.0268067
Published: 2022-05-19
Container: PLOS ONE
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0268067,
  title = {Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?},
  author = {Kenichi Kaneko and Ryosuke Miyasaka and Roslyn Hayman},
  year = {2022},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0268067},
  url = {https://doi.org/10.1371/journal.pone.0268067}
}

RIS

TY  - JOUR
TI  - Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
AU  - Kenichi Kaneko
AU  - Ryosuke Miyasaka
AU  - Roslyn Hayman
PY  - 2022
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0268067
UR  - https://doi.org/10.1371/journal.pone.0268067
ER  -

APA

Kaneko, K., Miyasaka, R., & Hayman, R. (2022). Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?. PLOS ONE. https://doi.org/10.1371/journal.pone.0268067

Source records

crossref · retrieved 2026-09-26T13:08:41.491Z